| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.49B | 18.50B | 18.35B | 18.02B | 16.33B | 16.10B |
| Gross Profit | 4.18B | 4.30B | 3.95B | 3.92B | 3.57B | 3.45B |
| EBITDA | 1.63B | 1.71B | 1.45B | 1.58B | 1.51B | 1.49B |
| Net Income | 1.30B | 1.56B | 1.26B | 1.07B | 989.67M | 944.70M |
Balance Sheet | ||||||
| Total Assets | 14.37B | 14.90B | 14.37B | 13.49B | 12.55B | 10.25B |
| Cash, Cash Equivalents and Short-Term Investments | 6.30B | 6.95B | 6.23B | 6.84B | 6.85B | 5.06B |
| Total Debt | 230.00M | 230.00M | 230.00M | 230.00M | 240.28M | 241.12M |
| Total Liabilities | 3.52B | 3.49B | 3.49B | 3.35B | 2.93B | 3.03B |
| Stockholders Equity | 10.85B | 11.40B | 10.87B | 10.13B | 9.62B | 7.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 469.00M | 216.00M | 974.95M | 879.39M | 971.81M |
| Operating Cash Flow | 0.00 | 767.00M | 255.00M | 1.04B | 891.96M | 1.02B |
| Investing Cash Flow | 0.00 | 371.00M | -68.00M | -259.85M | -304.71M | -134.34M |
| Financing Cash Flow | 0.00 | -521.00M | -780.00M | -672.01M | 1.10B | -324.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥14.97B | 9.83 | ― | 3.60% | 0.80% | 23.27% | |
67 Neutral | ¥11.14B | 9.17 | ― | 1.19% | 14.28% | 60.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥13.50B | 29.90 | ― | 1.75% | 12.78% | 56.92% | |
59 Neutral | ¥17.21B | -16.73 | ― | ― | 9.34% | -52.97% | |
59 Neutral | ¥14.22B | 46.76 | ― | ― | -2.04% | ― |